GMR outside the limits when using ABEL [Study As­sess­ment]

posted by Averroes – Spain, 2017-05-19 13:53 (2525 d 19:47 ago) – Posting: # 17372
Views: 6,324

Dear Helmut,

Recently we performed a full replicate (4-period) study using ABEL for EMA and actually the results shows AUC within 80-125, Cmax within expanded CI but unfortunately GMR fall outside 80-125.

I found in the forum that the GMR constrant is there for political reasons more than for scienfic or statistical reasons. Do you think we could still have an opportunity with European regulatory agencies?

Thanks,

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,661 registered users;
68 visitors (0 registered, 68 guests [including 4 identified bots]).
Forum time: 09:41 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5